The USAID Global Health Development Innovation Accelerator Broad Agency Announcement
ID: 273354Type: Posted
Overview

Buyer

Agency for International Development (USAID)

Award Range

$0 - $0

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Other

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Agency for International Development (USAID) is inviting organizations to participate in the Global Health Development Innovation Accelerator Broad Agency Announcement (BAA), aimed at co-creating and scaling innovative solutions to critical global health challenges. This initiative encourages diverse applicants, including public and private organizations, non-profits, and academic institutions, to submit proposals that address maternal and neonatal mortality through various funding stages, with awards typically reaching up to $250,000 for seed and validation projects and up to $2,000,000 for transitions to scale. The program emphasizes collaboration across disciplines and aims to leverage expertise to tackle health issues in low- and middle-income countries. Interested parties should refer to individual Addenda for specific submission timelines and contact information, as the response dates are determined by those Addenda.

    Files
    Title
    Posted
    The "Saving Lives at Birth" initiative, facilitated by USAID, aims to encourage innovative proposals to reduce maternal and neonatal mortality through a Broad Agency Announcement (BAA) and its Addendum. The program welcomes diverse organizations, including for-profit and non-profit entities, academic institutions, and civic groups, with specific eligibility requirements for applicants based on geographical focus and partnerships. Organizations can submit multiple proposals, and collaboration across disciplines is encouraged. The funding is categorized into seed, validation, and transition stages, with varying award amounts based on project scope—generally up to $250,000 for seed and validation projects and up to $2,000,000 for transitions to scale. The applications are restricted to an online submission process and a set timeline with no extensions. Successful applicants could begin implementation of their projects following the finalization of awards anticipated between September and December 2015. This program represents an important federal effort to leverage diverse expertise in tackling crucial health challenges in low-income and middle-income countries.
    Similar Opportunities
    The USAID Global Health Broad Agency Announcement for Research and Development (2018)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) has issued the Global Health Broad Agency Announcement (BAA) for Research and Development, aimed at fostering innovative solutions to critical global health challenges in developing countries. This BAA invites organizations to collaborate with USAID in co-creating research concepts that address significant health issues, such as maternal and child mortality and the prevention of infectious diseases, without directly soliciting funding proposals. The initiative emphasizes partnerships and cooperative engagements, focusing on the capability of participants to contribute to USAID's health objectives, with evaluations based on potential impact at scale. Interested parties can inquire further by contacting USAID at GH-BAA-2018@usaid.gov, with the BAA remaining open until May 30, 2022, for future Addenda that will provide specific funding information.
    INNOVATIVE HEALTH PRACTICES
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) is forecasting a grant opportunity titled "Innovative Health Practices" aimed at co-creating and scaling innovative research and development interventions to reduce disease and mortality rates globally. This Broad Agency Announcement (BAA) invites unrestricted organizations and companies to submit Expressions of Interest (EOI) to collaborate on generating novel tools and approaches that enhance health outcomes in low-and-middle-income countries (LMICs). The initiative emphasizes the importance of local partnerships and innovative practices in global health, seeking to leverage diverse expertise and resources to address health challenges effectively. Interested applicants can reach out to Sharon D. Davis at shdavis@usaid.gov or call 202-567-4755 for further information, with applications expected to follow an addendum to this announcement, which is anticipated to close in fiscal year 2024.
    Microbicides Research, Development, and Introduction
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is offering a federal grant opportunity titled "Microbicides Research, Development, and Introduction" aimed at advancing research and innovative activities related to microbicides for HIV prevention. This initiative seeks to support clinical trials and other activities that contribute to the Global Health Initiative's principles, particularly focusing on a woman- and girl-centered approach and strengthening health systems. The funding amounts range from $100,000 to $2,250,000, with no cost-sharing or matching requirements, and interested applicants can contact Kathleen Bumpass at kbumpass@usaid.gov for further information. The closing date for applications is to be determined.
    The USAID Fighting Ebola BAA
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is seeking innovative solutions through its Broad Agency Announcement (BAA) titled "The USAID Fighting Ebola BAA," aimed at combating the Ebola epidemic. This initiative invites public, private, for-profit, and non-profit organizations, as well as institutions of higher education and international organizations, to co-create and collaborate on practical innovations that enhance healthcare delivery and control the spread of Ebola. The program emphasizes the importance of developing cost-effective technologies to support healthcare workers on the front lines. Interested applicants must submit their expressions of interest by December 1, 2014, at 11:59 PM for consideration in the second round review, and can reach out to USAID at SubmitEbolaEOI@usaid.gov for further inquiries.
    MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health Services, Voluntary Family Planning, and Reproductive Health Care [MNCH/FP/RH] to Scale)
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is inviting concept papers for the MOMENTUM initiative, aimed at enhancing maternal, newborn, and child health services in high-burden areas, particularly in India. This opportunity seeks innovative proposals that focus on improving health outcomes through evidence-based interventions, capacity building of local health workers, and fostering partnerships with local institutions, with an emphasis on sustainability and alignment with government health strategies. The program anticipates awarding 1-3 grants, with a ceiling of $13 million, and requires concept papers to be submitted by August 21, 2020, with further co-creation workshops planned for selected applicants. For additional information, interested parties can contact Samantha Pierre at spierre@usaid.gov.
    Frontier Health Markets APS
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is inviting submissions for the Frontier Health Markets (FHM) Annual Program Statement (APS), aimed at enhancing global health outcomes related to maternal and child health, HIV/AIDS, and infectious diseases. This cooperative agreement seeks to engage both U.S. and non-U.S. organizations, including public, private, for-profit, and nonprofit entities, as well as institutions of higher education and international organizations, to submit concept papers for potential funding under various rounds of the APS. The initiative is critical for improving local health markets and fostering private sector involvement in health initiatives. Interested applicants can reach out to Jacquelin Bell at jacbell@usaid.gov for further information, with the closing date for submissions set for February 24, 2028.
    Augmenting Capacity for Humanitarian Emergencies of Infectious Diseases
    Active
    Agency for International Development
    The Agency for International Development (USAID) is offering a federal grant titled "Augmenting Capacity for Humanitarian Emergencies of Infectious Diseases" aimed at enhancing the preparedness and response capabilities of non-governmental organizations (NGOs) in the face of infectious disease outbreaks. The program seeks to establish standby capacity by improving technical coordination and multi-sectoral responses, particularly in health, nutrition, water, sanitation, and agriculture, to effectively manage humanitarian emergencies. With a total funding ceiling of $8 million for a single award, applicants are required to submit concept notes by April 27, 2018, and can direct inquiries to 720FDA18APS00001@ofda.gov for further clarification on the application process.
    Comprehensive District-Based Support for Better HIV/TB Patient Outcomes
    Active
    South Africa USAID-Pretoria
    The United States Agency for International Development (USAID) Mission to Southern Africa is seeking applications for a five-year cooperative agreement aimed at implementing comprehensive district-based HIV-related services to improve patient outcomes. This initiative is part of a broader effort to enhance health services in the region, specifically targeting better management and support for HIV and tuberculosis patients. With an estimated total program funding of $75 million, the agency anticipates awarding four grants, with individual awards ranging from $1 to $20 million. Interested organizations are encouraged to participate in a pre-application conference scheduled for May 14, 2012, in Johannesburg, South Africa, to clarify the application process and technical objectives; registration is required by January 23, 2012. For further inquiries, applicants can contact Beatrice Lumande at Applications4@usaid.gov or by phone at +27 12 452 2377.
    FY2024 Development Innovation Ventures_APS
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is inviting applications for the FY2024 Development Innovation Ventures (DIV) Annual Program Statement (APS), aimed at funding innovative solutions to international development challenges. This program supports various stages of project development, including pilot testing, rigorous testing and expansion, and scaling proven approaches, with a focus on evidence of impact and cost-effectiveness. The funding amounts range from $25,000 to $15 million, with applications accepted year-round, and compliance with System for Award Management (SAM) requirements is necessary prior to funding award. Interested applicants can reach out to Julia S. Banks at jbanks@usaid.gov for further information, with the application deadline set for November 1, 2024.
    New Partnerships Initiative (NPI) – Global Health
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is offering a funding opportunity through the New Partnerships Initiative (NPI) Global Health Annual Program Statement (APS) aimed at engaging new and underutilized partners to enhance health sector outcomes. This initiative focuses on supporting community-based interventions, particularly in response to COVID-19, by inviting organizations to submit Concept Papers that align with national health policies and emphasize local partnerships. The funding opportunity is significant, with a total ceiling of up to $100 million available for multiple awards, and the closing date for submissions is September 30, 2030. Interested applicants can reach out to USAID at ghnpiaps@usaid.gov for further information and guidance on the application process.